Class II ยท Moderate risk
Ganirelix Acetate Injection
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
National Drug Code
Is NDC 70748-0274-01 recalled?
Ganirelix Acetate · 1 TRAY in 1 CARTON (70748-274-01) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS
Yes — this exact package was recalled
1 FDA recall names the code 70748-0274-01 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
1 of these recalls is still ongoing.
- Active ingredient
- Ganirelix Acetate
- Strength
- GANIRELIX ACETATE 250 ug/.5mL
- Form
- Injection, Solution · Subcutaneous
- Labeler
- Lupin Pharmaceuticals, Inc.
- Type
- Human Prescription Drug
- Product code
- 70748-0274
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 70748-0153 Penicillamine 1
- 70748-0311 Glucagon 1
- 70748-0332 Prednisolone Acetate 1
- 70748-0346 Liraglutide 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.